关于募集资金使用完毕并注销募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 证券代码：603309 证券简称：维力医疗 公告编号：2025-039 广州维力医疗器械股份有限公司 截至本公告披露日，公司2021年非公开发行股票募集资金已按规定全部使用完毕，全部募集资金专户均 已注销完毕。 一、募集资金基本情况 经中国证券监督管理委员会《关于核准广州维力医疗器械股份有限公司非公开发行股票的批复》（证监 许可〔2021〕734号）核准，广州维力医疗器械股份有限公司（以下简称"公司"）以非公开发行股票方 式向特定投资者发行人民币普通股（A股）29,632,218股，发行价格为每股13.48元，募集资金总额为人 民币399,442,298.64元，募集资金净额为人民币392,814,940.16元。上述募集资金到位情况已经华兴会计 师事务所（特殊普通合伙）审验，并于2021年12月31日出具了《广州维力医疗器械股份有限公司验资报 告》（华兴验字[2021]21000110033号）。 截至本公告披露日，公司2021年非 ...

Core Viewpoint - The company has announced the use of its own funds to pay for investment projects and will subsequently replace these with raised funds, ensuring compliance with regulatory requirements and improving fund utilization efficiency [1][9][10]. Fundraising Overview - The company raised a total of RMB 2,314,200,000 from its initial public offering, with a net amount of RMB 2,145,746,574.65 after deducting issuance costs [1]. - In a subsequent issuance, the company raised RMB 1,781,656,587.99, with the funds fully received by October 23, 2023 [2]. Investment Project Details - The total investment for the initial public offering project was RMB 85,000,000, all of which has been completed [3]. - The company adjusted its fundraising project amounts, with a total of RMB 433,006.29 allocated for various projects, including RMB 375,953.25 for high-integration analog front-end and mixed-signal product development [4][6]. Reasons for Using Own Funds - The company intends to use its own funds for project payments to comply with banking regulations regarding salary payments and to enhance operational efficiency [6][7]. - Using own funds allows for bulk purchasing of materials and equipment, which is more cost-effective [7]. - The company aims to streamline the management of frequent and fragmented expenses related to project implementation [7]. Operational Process for Fund Replacement - The finance department will compile a detailed monthly report of expenditures paid with own funds, which will be reviewed and approved before transferring equivalent amounts from the fundraising account [8]. - A ledger will be maintained to track the replacement of own funds with raised funds, ensuring transparency and compliance with regulatory oversight [8]. Impact on Daily Operations - The decision to use own funds for project payments is expected to enhance the efficiency of fund utilization and project implementation without affecting the normal operation of the investment projects [9]. Review and Approval Process - The board of directors and the supervisory board have approved the use of own funds for project payments, confirming that the process adheres to legal and regulatory requirements [9][10].

Summary of Key Points Core Viewpoint - The company plans to temporarily use part of its idle raised funds, not exceeding RMB 60 million, to supplement its working capital, ensuring that this does not affect the normal implementation of its fundraising investment projects [6][7][8]. Group 1: Fundraising Overview - The company raised a total of RMB 754.38 million by issuing 51.67 million shares at RMB 14.60 per share, with actual funds received amounting to RMB 675.83 million after deducting issuance costs of RMB 78.55 million [1]. - The funds were deposited in a dedicated account for management [1]. Group 2: Investment Project Status - The company has approved the use of RMB 57 million of the raised funds to repay bank loans and has made adjustments to the implementation of certain investment projects without changing their overall direction or total investment amount [2][3]. - The company has also approved the use of remaining funds from the "Kunshan Hanjing Precision Connector Production Project" for new projects, including "Semiconductor Metal Heat Sink Material Project" and "Automotive High-Frequency Signal Cable and Connector Project" [3]. Group 3: Use of Idle Funds - The company intends to use idle funds temporarily to alleviate liquidity pressure, with an estimated savings of approximately RMB 1.8 million in financial costs based on a 3.0% annual loan interest rate [6]. - The use of these funds is limited to operations related to the company's main business and will not be used for high-risk investments or stock trading [6][7]. Group 4: Approval Process - The board of directors and the supervisory board have both approved the plan to use idle funds, confirming that it will not affect the normal operation of fundraising projects and will not harm shareholder interests [7][8].

Core Viewpoint - The report provides a verification of the use of previously raised funds by Suzhou Mawei Technology Co., Ltd., confirming that the funds have been utilized in accordance with regulatory requirements and that there are no significant misstatements in the financial reporting [1][2]. Summary by Sections Previous Fundraising Overview - The total amount raised from the issuance of shares was approximately RMB 608.50 million, with a net amount of RMB 604.69 million after deducting issuance costs [3]. - A second issuance raised approximately RMB 2.81 billion, with a net amount of RMB 2.79 billion after costs [4]. Fund Usage and Balance - As of December 31, 2024, the company has fully utilized the funds from the first issuance, totaling RMB 607.94 million [5]. - The remaining balance of unutilized funds as of December 31, 2024, is RMB 380.20 million, primarily held in structured deposits [5][6]. Fund Management - The company has established a fund management system in compliance with regulatory requirements to protect investor interests [5]. - A tripartite supervision agreement was signed with the sponsor and banks to ensure proper management of the raised funds [5]. Investment Project Performance - There have been no changes to the investment projects funded by the previous fundraising [6][7]. - The projects funded have not reported any inability to account for benefits separately, nor have they fallen below the promised return thresholds [7]. Idle Fund Management - The company has received approval to use idle funds for cash management, allowing for investment in low-risk financial products [8][9]. - As of December 31, 2024, the company has utilized idle funds for structured deposits, with a balance of RMB 380 million in such investments [9][10]. Comparison with Public Disclosures - The actual use of funds aligns with previously disclosed information in regular reports [10]. Other Matters - The company plans to use surplus funds from specific projects to supplement working capital for daily operations [10].

Group 1 - The company Shenzhen Jingzhida Technology Co., Ltd. has established a special account for the management of raised funds and signed a tripartite supervision agreement to ensure the proper use of these funds [2][4][5] - The company was approved by the China Securities Regulatory Commission to publicly issue 23,502,939 shares at a price of RMB 46.77 per share, raising a total of RMB 1,099.23 million, with a net amount of RMB 986.56 million after deducting issuance costs [2][3] - The special account was opened at a branch of Bank of China in Nanjing, and the balance as of May 16, 2025, was RMB 0 million, indicating that funds are being managed according to regulations [4][5] Group 2 - The tripartite supervision agreement includes provisions for the management and use of raised funds, ensuring that funds are strictly used for designated projects and not for other purposes [5][7] - The agreement stipulates that the sponsor, CITIC Securities, will supervise the use of funds and conduct at least biannual on-site investigations [5][7][8] - The agreement will remain effective until all funds are fully utilized and the account is closed, ensuring accountability and compliance with regulations [8][9] Group 3 - A significant shareholder, Shenzhen Guozhong SME Development Private Equity Investment Fund, has reduced its shareholding from 5,230,902 shares to 4,700,558 shares, decreasing its ownership from 5.56% to 5.00% [12][13] - This reduction in shareholding is part of a previously disclosed plan and does not trigger a mandatory tender offer or change the company's controlling shareholder [12][14] - The company emphasizes that this change will not affect its governance structure or ongoing operations [15]

证券代码：600935 证券简称：华塑股份 公告编号：2025-045 安徽华塑股份有限公司关于向特定对象 发行A股股票发行情况的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 安徽华塑股份有限公司（以下简称"公司"）本次向特定对象发行A股股票发行承销总结及相关文件已经 上海证券交易所备案通过，公司将依据相关规定尽快办理本次发行新增股份的登记托管事宜。 《安徽华塑股份有限公司向特定对象发行A股股票发行情况报告书》及相关文件已于同日在上海证券交 易所网站（www.sse.com.cn）披露，敬请广大投资者查阅。 特此公告。 安徽华塑股份有限公司董事会 2025年5月30日 证券代码：600935 证券简称：华塑股份 公告编号：2025-046 安徽华塑股份有限公司关于签订募集资金 专户存储三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意安徽华塑股份有限公司向特 ...

Core Points - The company held its third independent director meeting of 2025 on May 29, 2025, via communication methods to review relevant documents and ensure the protection of minority shareholders' interests [1] - The independent directors approved a proposal to establish a special account for raised funds and authorized the signing of a fund supervision agreement, ensuring compliance with relevant laws and regulations [1] Group 1 - The company plans to open a special account for raised funds at compliant financial institutions, managing the funds separately to protect investor interests [1] - The management of the raised funds will adhere to the requirements of the Company Law, Securities Law, and relevant regulatory guidelines, ensuring no harm to the company or shareholders [1]

十届二十五次董事会决议公告 股票代码：600491 股票简称：龙元建设 公告编号：临2025-025 龙元建设集团股份有限公司 第十届董事会第二十五次会议决议公告 一、审议通过了《关于设立募集资金专用账户并授权签署募集资金监管协议 的议案》 为规范公司募集资金的使用和管理，保护投资者权益，根据《中华人民共和 国公司法》《中华人民共和国证券法》《上市公司监管指引第 2 号-上市公司募 集资金管理和使用的监管要求》等相关规定，同意公司在符合规定的金融机构开 立募集资金专用账户，对本次发行的募集资金实行专户专储管理，并按照规定与 保荐人、存放募集资金的商业银行签署募集资金监管协议，对募集资金的存放和 使用情况进行监管。董事会同意授权公司管理层及其授权人士办理募集资金专用 账户的开立、募集资金监管协议签署等相关事项。 表决结果：同意 4 票，反对 0 票，弃权 0 票，回避表决 3 票。 关联董事赖朝辉、王初琛、吕江回避表决。 本议案已经公司独立董事专门会议 2025 年第三次会议审议通过。 特此公告。 龙元建设集团股份有限公司 董 事 会 十届二十五次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚 ...

证券代码：688395 证券简称：正弦电气 公告编号：2025-027 深圳市正弦电气股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 监事会会议召开情况 《上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相关法 律法规、规范性文件和公司《募集资金管理制度》的规定，不会对公司的正常经 营活动造成重大不利影响。 表决情况：3 票同意，0 票反对，0 票弃权。 深圳市正弦电气股份有限公司（以下简称"公司"）第五届监事会第九次会 议（以下简称"本次会议"）于 2025 年 5 月 29 日上午 11:00 以现场结合通讯方 式在公司会议室召开，本次会议通知及相关材料已于 2025 年 5 月 23 日以电子邮 件方式送达公司全体监事。本次会议由监事会主席欧阳博先生主持，会议应到监 事三人，实到监事三人。本次会议的召集、召开符合《中华人民共和国公司法》 等法律法规、规章、规范性文件和《公司章程》的有关规定。 二、监事会会议审议情况 经与会监事审议，做出如下决 ...

Group 1 - The company has established a special account for the storage of raised funds and signed a four-party supervision agreement to ensure compliance with regulations and protect investors' rights [2][3] - The total amount raised from the issuance of convertible bonds is RMB 543.31 million, with a net amount of RMB 532.698 million after deducting related expenses [1] - The special account is exclusively for the use of funds related to the medical consumables centralized operation service project, and cannot be used for other purposes [3][4] Group 2 - The four-party supervision agreement involves the company, its subsidiary, the underwriting institution, and the bank, ensuring proper management of the raised funds [2][3] - The agreement stipulates that the underwriting institution will conduct ongoing supervision and can perform site investigations and inquiries regarding the special account [3][4] - The agreement will remain effective until all funds in the special account are fully utilized and the account is legally closed [4]